The Department of Neurology, Univ. at Buffalo School of Medicine and Biomedical Sciences, will present an update on neurology for primary care providers on March 14, 2015, to be held in the Gates Vascular Institute building, Clinical Translational Research Center, 5th floor, on the Buffalo Niagara Medical Campus adjacent to Buffalo General Medical Center. Topics will include the approach to the neurological patient as well as management of common disorders such as stroke, epilepsy, memory disorders, and neuropathic pain. In addition, an account of neurologic problems affecting Presidents of the United States through our country’s history will be presented. Please check this site for further information about registration or call 716-859-7540
Ashkan Mowla, MD, Assistant Professor in the Univ. at Buffalo (UB) Dept. of Neurology, directed a recent study to examine the safety of intravenous tissue plasminogen activator (tPA) in stroke patients who had brain neoplasms. Intracranial neoplasms (tumors) are currently a contraindication for IV tPA due to concerns for a risk of bleeding. In the retrospective study of some 637 patients who received IV tPA through the UB stroke program, 13 were found to have intracranial neoplasms. None of the patients suffered symptomatic intracranial bleeding or bleeding into the tumor. The authors, including Dept. of Neurology faculty Peyman Shirani, MD, Robert Sawyer, MD, and Marilou Ching, MD, MPH, neurology residents Karanbir Singh, MBBS and Haris Kamal, MD, and stroke research coordinator Annemarie Crumlish, CCRC, will be presenting their findings at the International Stroke Conference in 2015. A full-length manuscript in the International Journal of Stroke has been accepted for publication with Dr. Singh, a PGY-4 resident, serving as first author.